Paraplegia News and Research

RSS
Paraplegia is an impairment in motor or sensory function of the lower extremities. It is usually the result of spinal cord injury or a congenital condition such as spina bifida which affects the neural elements of the spinal canal.
FDA approves marketing of first motorized device for patients with spinal cord injuries

FDA approves marketing of first motorized device for patients with spinal cord injuries

HAL robot suit helps paraplegics

HAL robot suit helps paraplegics

New potential treatment for paraplegic patients

New potential treatment for paraplegic patients

Study shows spinal stimulation therapy may have potential to change prognosis of people with paralysis

Study shows spinal stimulation therapy may have potential to change prognosis of people with paralysis

UC San Diego researchers uncover causes for hereditary spastic paraplegia

UC San Diego researchers uncover causes for hereditary spastic paraplegia

ARGO Medical partners with YASKAWA for global expansion of ReWalk exoskeleton device

ARGO Medical partners with YASKAWA for global expansion of ReWalk exoskeleton device

Journal of Spinal Cord Medicine's July issue focuses on assistive technology for spinal cord injury

Journal of Spinal Cord Medicine's July issue focuses on assistive technology for spinal cord injury

ARGO launches ReWalk Rehabilitation 2.0 system

ARGO launches ReWalk Rehabilitation 2.0 system

Bionic devices: an interview with Dr Rylie Green

Bionic devices: an interview with Dr Rylie Green

University of Tübingen heads Neuromics consortium

University of Tübingen heads Neuromics consortium

Powered exoskeleton provides more independence to people with severe spinal cord injuries

Powered exoskeleton provides more independence to people with severe spinal cord injuries

Neuralstem prices registered direct offering of 7,000,000 shares of common stock

Neuralstem prices registered direct offering of 7,000,000 shares of common stock

Q Therapeutics licenses Neuralstem's Spinal Cord Delivery Platform and Floating Cannula

Q Therapeutics licenses Neuralstem's Spinal Cord Delivery Platform and Floating Cannula

Preliminary research findings from Kessler Foundation’s Ekso device study on SCI

Preliminary research findings from Kessler Foundation’s Ekso device study on SCI

ARGO Medical, Cyclone Technologies announce availability of ReWalk exoskeleton system

ARGO Medical, Cyclone Technologies announce availability of ReWalk exoskeleton system

Exoskeleton technology now available to take home

Exoskeleton technology now available to take home

Neuralstem completes NSI-566 Phase I trial on amyotrophic lateral sclerosis

Neuralstem completes NSI-566 Phase I trial on amyotrophic lateral sclerosis

Advanced understanding of neurodegenerative diseases achieved by Trophos

Advanced understanding of neurodegenerative diseases achieved by Trophos

Neuralstem commences dosing in NSI-189 Phase Ib trial for major depressive disorder

Neuralstem commences dosing in NSI-189 Phase Ib trial for major depressive disorder

Stem Cells reports results of Neuralstem ALS Phase I trial

Stem Cells reports results of Neuralstem ALS Phase I trial